Mitochondrial targeting derivatives of honokiol enhanced selective antitumor activity in NCI-H446 cells and decreased in vivo toxicity in Caenorhabditis elegans
- 3 December 2023
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 264, 115996
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874296)
This publication has 30 references indexed in Scilit:
- Enabling Mitochondrial Uptake of Lipophilic Dications Using Methylated Triphenylphosphonium MoietiesInorganic Chemistry, 2019
- Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targetsPharmacological Research, 2019
- Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancerPhytomedicine, 2019
- Cell Biology of the MitochondrionGenetics, 2017
- Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic ApplicationsChemical Reviews, 2017
- A ROS rheostat for cell fate regulationTrends in Cell Biology, 2013
- Apoptosis in cancer: from pathogenesis to treatmentJournal of Experimental & Clinical Cancer Research, 2011
- Approaches for targeting mitochondria in cancer therapyBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cellsLife Sciences, 1994
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972